Phase I/II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma Meeting Abstract
| Authors: | Ratner, L.; Ramos, J. C.; Noy, A.; Barta, S.; Parikh, S.; Phillips, A.; Ambinder, R.; Rauch, D.; Harding, J.; Baydoun, H.; Cheng, X. G.; Caruso, B.; Jacobson, S. |
| Abstract Title: | Phase I/II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma |
| Meeting Title: | 17th International Conference on Human Retrovirology: HTLV & Related Viruses (HTLV 2015) |
| Journal Title: | Retrovirology |
| Volume: | 12 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Jun 18-21 |
| Meeting Location: | Trois Ilets, Martinique |
| ISSN: | 1742-4690 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2015-08-28 |
| Language: | English |
| ACCESSION: | WOS:000367468500062 |
| PROVIDER: | wos |
| PMCID: | PMC4578736 |
| DOI: | 10.1186/1742-4690-12-S1-P21 |
| PUBMED: | 26351861 |
| Notes: | Meeting Abstract: P21 -- Source: Wos |
